ArticlePharmaceuticals (Basel, Switzerland)2022

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma.

Mascha Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.